Evolent Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Evolent Health, Inc. on May 4, 2020. The filing primarily addresses executive leadership changes and references the announcement of financial results for the quarter ended March 31, 2020, which were issued via a press release on May 7, 2020.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the body of this report.
Material Changes and Executive Leadership
Significant changes to the Company's principal officers were announced effective June 30, 2020:
- Resignation: Thomas Peterson, Chief Operating Officer (COO), notified the Company of his resignation. He will continue to serve as an advisor and as a member of the Passport Health Plan, Inc. Board of Directors.
- Appointment: Steve Tutewohl was appointed as the new Chief Operating Officer. Mr. Tutewohl, 48, has served as CEO of Evolent Health Services since January 2018 and previously served as the Company's Chief Actuary (2017) and Strategic Accounts Officer (1996-2017).
Guidance, Outlook, and Risks
The filing does not contain specific guidance, outlook, or risk commentary within the text provided. Investors are directed to the press release (Exhibit 99.1) for details regarding the financial results for the quarter ended March 31, 2020. No unusual items or contingencies were disclosed in the text of this 8-K.
Key Facts for Investor Verification
- Verify the specific financial performance metrics (revenue, net income, cash flow) for the quarter ended March 31, 2020, by reviewing the press release dated May 7, 2020 (Exhibit 99.1).
- Confirm the transition timeline for the COO role, with Thomas Peterson departing and Steve Tutewohl assuming the position on June 30, 2020.
- Review Mr. Tutewohl's background to assess his experience leading the Evolent Health Services division and his prior actuarial and strategic account roles.